AI Article Synopsis

  • Priapism, a rare yet urgent condition associated with Chronic Myeloid Leukaemia (CML), can lead to impotence if not treated promptly.
  • Treatment options include medications like hydroxyurea and analgesics, along with surgical interventions and therapies like leukapheresis which effectively lowers leukocyte counts.
  • In a reported case, multiple treatments were tried but failed to relieve pain until leukapheresis was administered, significantly reducing the priapism pain.

Article Abstract

Priapism is a rare presentation of Chronic Myeloid Leukaemia (CML). It is also considered a medical emergency as delay in treatment may lead to impotence. Prompt medical and surgical interventions such as hydroxyurea, analgesia, phenylephrine injection and aspiration, open surgical shunting, and local radiation therapy are essential. Leukapheresis effectively reduces leukocyte count rapidly and effectively, thereby an important therapy along with other standard of care in CML-induced priapism. In the present case, priapism was the presenting symptom of CML. The same was managed with various modalities such as hydroxyurea, allopurinol, antibiotics, analgesics, sedatives, phenylephrine injection, and aspiration but failed to reduce priapism pain. With a single cycle of leukapheresis, priapism pain could be reduced significantly.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528545PMC
http://dx.doi.org/10.4103/ajts.ajts_160_21DOI Listing

Publication Analysis

Top Keywords

phenylephrine injection
8
injection aspiration
8
priapism pain
8
priapism
6
leukapheresis pain
4
pain reduction
4
reduction leukemic
4
leukemic priapism
4
priapism priapism
4
priapism rare
4

Similar Publications

Background And Objective: Reports have suggested the use of intravenous infusion of vasopressors as an approach to prevent spinal anesthesia-induced hypotension (SAIH) in women undergoing cesarean deliveries. However, data on the suitability of this technique for obese people are limited. As such, the current experiment was designed to clarify the dose-response relationship associated with the preventive administration of phenylephrine to avoid SAIH during cesarean delivery in obese parturients under combined spinal-epidural anesthesia.

View Article and Find Full Text PDF
Article Synopsis
  • * Multiple initial interventions, including medications and cold compresses, failed to resolve the persistent PE before the surgery could proceed.
  • * The successful resolution of PE was achieved with an intracavernous injection of phenylephrine, demonstrating its effectiveness and the need for adaptability in managing such complications in pediatric surgeries.
View Article and Find Full Text PDF

Background: Intravenous fluid administration and prophylactic vasopressor infusion are the primary methods for preventing spinal anesthesia-induced hypotension during cesarean delivery. However, evidence regarding the impact of different volumes of crystalloid solution on the phenylephrine infusion dosage for preventing this hypotension remains inconclusive. This study aimed to determine the effect of two IV fluid infusion rates (10 or 20 mL/kg/h) on phenylephrine requirement for preventing spinal anesthesia-induced hypotension.

View Article and Find Full Text PDF

Catecholamine dysregulation is a common feature of multiple acute and chronic cardiac conditions, including heart failure. To investigate the role of altered α-adrenergic stimulation on cardiac function, we developed a short-term exposure model, administering phenylephrine subcutaneously to mice for one week. Compared to vehicle-injected controls, phenylephrine-treated animals exhibited increased ejection fraction, decreased chamber size, diastolic dysfunction and ventricular hypertrophy in the absence of hypertension.

View Article and Find Full Text PDF

PFKP inhibition protects against pathological cardiac hypertrophy by regulating protein synthesis.

Biochim Biophys Acta Mol Basis Dis

January 2025

Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200000, China. Electronic address:

Metabolic reprogramming precedes most alterations during pathological cardiac hypertrophy and heart failure (HF). Recent studies have revealed that Phosphofructokinase, platelet (PFKP) has a wealth of metabolic and non-metabolic functions. In this study, we explored the role of PFKP in cardiac hypertrophic growth and HF.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!